- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/78 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 233/78
Total number of patents in this class: 69
10-year publication summary
|
4
|
10
|
3
|
5
|
6
|
4
|
1
|
2
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 1465 |
7 |
| Vectus Biosystems Limited | 29 |
6 |
| Sumitomo Chemical Company, Limited | 8996 |
4 |
| Lakefront Biotherapeutics | 35 |
4 |
| Allergan, Inc. | 2169 |
3 |
| President and Fellows of Harvard College | 6091 |
3 |
| Kyushu University, National University Corporation | 1707 |
3 |
| Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences | 193 |
3 |
| Bristol-myers Squibb Company | 4729 |
2 |
| F. Hoffmann-La Roche AG | 7836 |
2 |
| The Board of Trustees of the University of Illinois | 2750 |
2 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1018 |
2 |
| Kowa Company, Ltd. | 1234 |
2 |
| Mitsubishi Tanabe Pharma Corporation | 406 |
2 |
| Firmenich Incorporated | 156 |
2 |
| Sanofi-Aventis Deutschland GmbH | 2593 |
1 |
| Abbvie Inc. | 1836 |
1 |
| China Pharmaceutical University | 358 |
1 |
| Elanco US Inc. | 718 |
1 |
| Eternity Bioscience Inc. | 15 |
1 |
| Other owners | 17 |